Citations

Showing 10 of 108104 citations.

Down Syndrome Cures: Perspectives of People With Down Syndrome and Their Parents
Rogers, Julie M., Weaver, Amy L. , Havyer, Rachel D. , Rogers, Julie M.G.

Mayo Clinic

American Journal on Intellectual and Developmental Disabilities | April 20, 2022 | Volume: 127 | Issue: 3 | Pages: 194-212

10.1352/1944-7558-127.3.194 | PMID 35443053 Get It

Abstract Down syndrome (DS) research is advancing rapidly, yet efforts have raised ethical questions. This mixed methods study describes views of people with DS (self-advocates) and their parents regarding medical interventions for DS. Responses from 35/171 (20.5%) self-advocates and 430/867 (49.6%) parents showed the majority of self-advocates were glad they have DS (27/35; 77.1%) and liked who they are (33/35; 94.3%), but did want to learn faster (23/35; 65.7%). Parents much more commonly agreed with a willingness to give medications to prevent Alzheimer's disease (427/429; 99.5%) or blood cancer (428/430; 99.5%) as compared with a medicine to cure DS (225/425; 52.9%). Qualitative comments intertwined DS with identity, yet indicated desire for improved quality of life and opportunities. Responses decoupled DS itself from the complications of DS, with treatment of complications being more acceptable.
Social Support, Social Isolation, and Burnout: Cross-Sectional Study of U.S. Residents Exploring Associations With Individual, Interpersonal, Program, and Work-Related Factors
West, Colin P. , Rackley, Sandra , Dozois, Eric J. , Moeschler, Susan M. , Stelling, Brianna E. Vaa , Satele, Daniel , Leep Hunderfund, Andrea N, Rackley, Sandra J, Vaa Stelling, Brianna E, Winters, Richard C. , Satele, Daniel V, Dyrbye, Liselotte N. , West, C P , Hunderfund, Andrea N. Leep

Mayo Clinic

Academic Medicine | April 20, 2022 | Volume: 97 | Issue: 8 | Pages: 1184-1194

10.1097/acm.0000000000004709 | PMID 35442910 Get It

Abstract Purpose To examine associations of social support and social isolation with burnout, program satisfaction, and organization satisfaction among a large population of U.S. residents and fellows and to identify correlates of social support and social isolation. Method All residents and fellows enrolled in graduate medical education programs at Mayo Clinic sites were surveyed in February 2019. Survey items measured social support (emotional and tangible), social isolation, burnout, program satisfaction, and organization satisfaction. Factors of potential relevance to social support were collected (via the survey, institutional administrative records, and interviews with program coordinators and/or program directors) and categorized as individual, interpersonal, program, or work-related factors (duty hours, call burden, elective time, vacation days used before survey administration, required away rotations, etc.). Multivariable regression analyses were conducted to examine relationships between variables. Results Of 1,146 residents surveyed, 762 (66%) from 58 programs responded. In adjusted models, higher emotional and tangible support were associated with lower odds of burnout and higher odds of program and organization satisfaction, while higher social isolation scores were associated with higher odds of burnout and lower odds of program satisfaction and organization satisfaction. Independent predictors of social support and/or social isolation included age, gender, relationship status, parental status, postgraduate year, site, ratings of the program leadership team, ratings of faculty relationships and faculty professional behaviors, satisfaction with autonomy, and vacation days used before survey administration. Conclusions This study demonstrates that social support and social isolation are strongly related to burnout and satisfaction among residents and fellows. Personal and professional relationships, satisfaction with autonomy, and vacation days are independently associated with social support and/or social isolation, whereas most program and work-related factors are not. Additional studies are needed to determine if social support interventions targeting these factors can improve well-being and enhance satisfaction with training.
Reimagining Faculty Development Deployment: A Multipronged, Pragmatic Approach to Improve Engagement
Dyrbye, Liselotte N. , Bergene, Angela L, Hunderfund, Andrea N Leep, Billings, Heather A, Billings, Heather , Leep Hunderfund, Andrea N, Dyrbye, Liselotte N , Billings, Heather , Bergene, Angela L, Hunderfund, Andrea N Leep

Mayo Clinic

Academic Medicine | April 20, 2022 | Volume: 97 | Issue: 9 | Pages: 1322-1330

10.1097/acm.0000000000004688 | PMID 35442909 Get It

Abstract Problem Faculty at academic health centers have many competing demands on their time, leading to high work stress, burnout, and limited capacity to meaningfully improve their teaching, evaluation, feedback, and other education-related skills. Faculty development provides a useful mechanism to assist faculty in enhancing their knowledge and skills in these areas, but engaging faculty can be a challenge. Approach To promote engagement, the authors developed a multipronged, pragmatic approach to faculty development. They created: (1) brief videos leveraging micro-learning strategies; (2) prepackaged workshops for use during existing faculty meetings; (3) a newsletter to raise awareness of faculty development opportunities; (4) a searchable, web-based catalog to facilitate rapid retrieval of faculty development content; and (5) an academy to acknowledge engagement of individual faculty members, provide certificates, and promote a culture that prioritizes our education mission. Outcomes Since they launched the new approach in 2017, they have developed 41 microlearning videos, 15 prepackaged workshops, and 24 issues of the newsletter. Between January 2017 and May 2021, the videos generated more than 150,055 views; the workshops were downloaded 2,850 times; and the issues of the newsletter, emailed bimonthly to 3,500 members of the faculty, had an open rate that increased from 30% in 2017 to 70% in 2021. The Academy of Educational Excellence, which was launched in 2018, grew to more than 490 members. Preliminary feedback suggests faculty and education leaders are highly satisfied with the faculty development resources and approaches to engagement. Next Steps Next steps include obtaining more user satisfaction data and evaluating whether education-related knowledge and skills have improved among faculty participants.
Traumatic cervical spine distraction injury
Robinson, Kristin A. , Jorgensen, Scott A., Towbin, Richard B. , Towbin, Alexander J.

Mayo Clinic

Applied Radiology | April 20, 2022 | Volume: No volume available | Issue: No issue available | Pages: 28-30

10.37549/ar2191 Get It

Cytomorphology of NUTM1‐rearranged sarcoma involving pleural fluid
Chen, Longwen , Larsen, Brandon T. , Zarka, Matthew A., Larsen, Brandon, Chen, Longwen , Dermawan, Josephine K.

Mayo Clinic

Diagnostic Cytopathology | April 20, 2022 | Volume: 50 | Issue: 9 | Pages: No page available

10.1002/dc.24968 | PMID 35441831 Get It

AbstractWe describe an exceedingly rare cytology case of a NUTM1‐rearranged sarcoma involving pleural fluid. A 48‐year‐old female presented with progressive abdominal pain. Computed tomography (CT) scan of the abdomen revealed a 5.6 cm soft tissue mass in the right hemi‐abdomen. Needle core biopsy of the mass showed a small round cell tumor. Extensive work‐up including next generation sequencing (NGS) demonstrated a NUTM1:MXI1 rearranged sarcoma. The patient was first treated with ifosfamide, carboplatin, and etoposide (ICE) chemotherapy. She responded initially and then progressed with multiple masses in the abdomen and pleural effusion. The cytology of the pleural effusion showed clusters and single small round blue cells. Some of them displayed rhabdoid morphology. Immunostains of NUT antibody on cell block demonstrated strong positivity of NUT. NUTM1‐rearranged sarcoma is an emerging class of mesenchymal neoplasm and the cytomorphology of this neoplasm in liquid‐based cytology (LBC) is yet to be described. We herein reported the first cytology case of NUTM1‐rearranged sarcoma in pleural fluid.
The Brief Case: Sister Fungi in a Patient with AIDS
Misra, Anisha , Roiko, Marijo S. , Saleh, Omar Abu , Morris, Heather, Pritt, Bobbi S. , Roiko, Marijo , Abu Saleh, Omar , Pritt, Bobbi S

Mayo Clinic

Journal of Clinical Microbiology | April 20, 2022 | Volume: 60 | Issue: 4 | Pages: No page available

10.1128/jcm.01144-21 | PMID 35442074 Get It

“It’s Like You Stuck a Pin in It:” African American/Black Patients Describe Cutaneous Toxicity From Epidermal Growth Factor Receptor Inhibitors
Martin, Nichole , Asiedu, Gladys B. , Jatoi, Aminah , Nguyen, Phuong L., Martin, Nichole A, Asiedu, Gladys, Jatoi, Aminah , Tran, Nguyen H. , Nguyen, Phuong , Le‐Rademacher, Jennifer

Mayo Clinic

American Journal of Hospice and Palliative Medicine® | April 20, 2022 | Volume: 40 | Issue: 3 | Pages: 337-340

10.1177/10499091221092698 | PMID 35442101 Get It

Background: Epidermal growth factor receptor (EGFR) inhibitors cause cutaneous toxicity in over 90% of patients. Conceivably, healthcare providers could overlook such toxicity in African American/Black patients because of a darker complexion. This qualitative study sought to learn about such cutaneous signs and symptoms and, if present, to report them in patients’ own words. Methods: Any patient who self-identified as African American/Black and who had been prescribed an EGFR inhibitor was eligible. The current report focuses on patients’ responses to the following question, “What have you noticed since starting your cancer treatment (the EGFR inhibitor), any particular symptoms or reactions, positive or negative?” All interview data were audio-recorded, transcribed, and then independently coded and analyzed by two investigators. Results: Fifteen patients are the focus of this report, and all described cutaneous toxicity. Patients appeared troubled by the cosmetic aspect of these drug-induced skin changes, including their acneiform appearance, describing “little pimples with little, little pus in it.” Notable were comments on hyperpigmentation, “I’m a black person but…. became darker.” Furthermore, patients experienced physical symptoms: “it itches;” “it’s like you stuck a pin in it;” “stinging;” and “burning;”. Conclusion: Although cutaneous toxicity from EGFR inhibitors might be more difficult to visualize among darkly complected patients, the graphic descriptions offered in this qualitative study underscore the need for clinicians to heighten their awareness of such toxicity in African American/Black patients.
Chronic Neck Pain and Swelling in a Teenage Patient: An Unusual Association of Inflammatory Bowel Disease
Shamim, Huma, Khan, Muhammad Rehan , Absah, Imad

Mayo Clinic

Clinical Pediatrics | April 20, 2022 | Volume: 61 | Issue: 7 | Pages: 503-506

10.1177/00099228221088719 | PMID 35442118 Get It

Treatment and Management of Autosomal Recessive Cerebellar Ataxias: Current Advances and Future Perspectives
Dupré, Nicolas , Salem, Ikhlass Haj, Beaudin, Marie , Klein, Christopher J.

Mayo Clinic

CNS & Neurological Disorders - Drug Targets | April 20, 2022 | Volume: 22 | Issue: 5 | Pages: 678-697

10.2174/1871527321666220418114846 | PMID 35440322 Get It

Abstract:The autosomal recessive cerebellar ataxias (ARCAs) compose a clinically and genetically heterogeneous group of neurodegenerative diseases characterized by prominent cerebellar ataxia, dysmetria, dysarthria, and nystagmus that are inherited in an autosomal recessive fashion. The diagnosis of ARCAs is challenging because of their low prevalence, poor medical recognition, and heterogeneous clinical presentation with many overlapping features between entities. There currently exist no disease-modifying therapies for most ARCAs, and treatment is mainly symptomatic, aimed at prolonging independence and maintaining the quality of life. As knowledge of the common pathogenic pathways underlying several ARCAs grows, so do these pathways to target with new drugs. Chelation or enzyme replacement therapies are available for some specific ataxias caused by amenable metabolic alterations. A large number of drug trials are ongoing and aim to identify new therapeutic approaches to expand the options in our repertoire. Improved protocols of motor rehabilitation and noninvasive cerebellar stimulation have been shown to delay disease progression and maintain quality of life. Furthermore, recent progress in gene and molecular targeting therapies is rapidly expanding and holds promise for repairing defective genes. Neurotransplantation of grafted stem cells, which is still at the experimental preclinical stage, has opened new therapeutic strategies aimed at delaying cell degeneration and facilitating compensatory functions. This article is an overview of the current management and treatment strategies with an emphasis on promising perspectives for patients with ARCAs.
Seizure forecasting using minimally invasive, ultra‐long‐term subcutaneous EEG: Generalizable cross‐patient models
Attia, Tal Pal , Viana, Pedro F. , Nasseri, Mona , Duun‐Henriksen, Jonas , Biondi, Andrea , Winston, Joel S. , Martins, Isabel Pavão , Nurse, Ewan S. , Dümpelmann, Matthias , Worrell, Gregory A. , Schulze‐Bonhage, Andreas , Brinkmann, Benjamin H. , Richardson, Mark P. , Pal Attia, Tal , Pavão Martins, Isabel , Freestone, Dean R , Brinkmann, Benjamin H , Richardson, Mark P , Nurse, Ewan , Schulze-Bonhage, Andreas , Dümpelmann, Matthias , Worrell, Gregory A , Duun-Henriksen, Jonas , Biondi, Andrea , Winston, Joel S , Viana, Pedro F , Freestone, Dean R. , Kjaer, Troels W

Mayo Clinic

Epilepsia | April 20, 2022 | Volume: 64 | Issue: S4 | Pages: No page available

10.1111/epi.17265 | PMID 35441703 Get It

Abstract This study describes a generalized cross‐patient seizure‐forecasting approach using recurrent neural networks with ultra‐long‐term subcutaneous EEG (sqEEG) recordings. Data from six patients diagnosed with refractory epilepsy and monitored with an sqEEG device were used to develop a generalized algorithm for seizure forecasting using long short‐term memory (LSTM) deep‐learning classifiers. Electrographic seizures were identified by a board‐certified epileptologist. One‐minute data segments were labeled as preictal or interictal based on their relationship to confirmed seizures. Data were separated into training and testing data sets, and to compensate for the unbalanced data ratio in training, noise‐added copies of preictal data segments were generated to expand the training data set. The mean and standard deviation (SD) of the training data were used to normalize all data, preserving the pseudo‐prospective nature of the analysis. Different architecture classifiers were trained and tested using a leave‐one‐patient‐out cross‐validation method, and the area under the receiver‐operating characteristic (ROC) curve (AUC) was used to evaluate the performance classifiers. The importance of each input signal was evaluated using a leave‐one‐signal‐out method with repeated training and testing for each classifier. Cross‐patient classifiers achieved performance significantly better than chance in four of the six patients and an overall mean AUC of 0.602 ± 0.126 (mean ± SD). A time in warning of 37.386% ± 5.006% (mean ± std) and sensitivity of 0.691 ± 0.068 (mean ± std) were observed for patients with better than chance results. Analysis of input channels showed a significant contribution ( p < .05) by the Fourier transform of signals channels to overall classifier performance. The relative contribution of input signals varied among patients and architectures, suggesting that the inclusion of all signals contributes to robustness in a cross‐patient classifier. These early results show that it is possible to forecast seizures training with data from different patients using two‐channel ultra‐long‐term sqEEG.